Abstract:disease (CHD) or atherosclerosis is elevated levels of serum cholesterol. Recent clinical trials and studies have confirmed that lowering of low-density lipoprotein (LDL) cholesterol is related to a reduction in CHD risk. The reduction of serum cholesterol levels has mainly been accomplished by inhibiting cholesterol biosynthesis or by blocking the absorption of dietary cholesterol. Statins, such as pravastatin, that effectively inhibit cholesterol biosynthesis are HMG-CoA reductase (3-hydroxy-3-methylglutaryl-coenzyme A reductase) inhibitors and are widely prescribed in the treatment of hypercholesterolemia. Several squalene synthesis inhibitors have been also reported. SCH-48461 (a trans-azetidinone) and 4 ,6 -bis((2-fluorophenyl)carbamoyl) b-O-cellobioside (a steriodal glycoside) have recently been reported to be cholesterol absorption inhibitors. Phytosterols, or plant sterols, are an interesting class of compound due to their application and biological activities. The phytosterols found most frequently in nature are b-sitosterol, campesterol, and stigmasterol. It has been known that they inhibit the absorption of dietary and endogenously produced cholesterol from the small intestine, reducing blood cholesterol concentrations both in animal models and in humans. b-Sitosterol and b-sitostanol fatty acid esters were recently commercialized as food additives to reduce serum cholesterol levels. A novel hydrophilic phytostanol analogue, FM-VP4, was also developed to reduce serum cholesterol levels. However, even with the current therapeutic agents, it is not easy to achieve proper plasma cholesterol levels without side effect. Therefore the discovery of more effective, well-tolerated agents that reduce high cholesterol levels is needed. We here report the synthesis and interesting pharmacologic properties of novel succinamic acid ester derivatives that are bsitosterol analogues, compounds 1 and 2, that have the ability to lower plasma cholesterol levels and that can be more effective cholesterol-lowering alternatives to b-sitosterol and bsitostanol fatty acid esters. Chemistry The synthesis of b-sitosterol analogues 1 and 2 are summarized Chart 1. The b-sitosterol-3-hemisuccinate ester 1 was prepared by the reaction of b-sitosterol and succinic anhydride in toluene with a catalytic amount of DMAP. The chlorination of the resulting acid compound 1 with SOCl2 and then direct amination with appropriate amines afforded N-substituted succinamic acid b-sitosteryl ester derivatives 2. Compounds 2 were also synthesized in 76—92% yields by the reaction of 1 with methyl chloroformate, followed by amination of the activated intermediate. Interestingly, compound 2a (DANA87) was also easily obtained in one step by the direct addition of b-sitosterol to dicyclohexylcarbodiimide (DCC) in 80% yield. It was considered that compound DANA87 was prepared by slow thermal degradation of the May 2004 Notes Chem. Pharm. Bull. 52(5) 597—601 (2004) 597

Impact of molecular interactions between hydrophilic phytosterol glycosyl derivatives and bile salts on the micellar solubility of cholesterol

Catalyst-free synthesis of phytosterol diacid monoesters and their competitive effect on the solubilization of cholesterol in model bile mixed micelles

The Effect of Whey Protein Isolate Hydrolysate on Digestive Properties of Phytosterol

Phytosterol Organic Acid Esters: Characterization, Anti-Inflammatory Properties and a Delivery Strategy to Improve Mitochondrial Function

Biopolymer-based Sequestrants for Lowering Cholesterol: Structures, in Vitro Bile Acid Anion Binding Effects, and Interaction Mechanisms

Improved Water-Solubility of Phytosterol by Hydroxypropyl-β-Cyclodextrin

Mechanisms of decreased cholesterol absorption mediated by phytosterols in the intestinal lumen

The Bioavailability and Biological Activities of Phytosterols as Modulators of Cholesterol Metabolism

Enhancement of Galloylation Efficacy of Stigmasterol and Β-Sitosterol Followed by Evaluation of Cholesterol-Reducing Activity.

Molecular dynamics simulations of the interfacial behaviors and photo-oxidation of phytosterol under different emulsion oil content

Novel Guanidinium-Functionalized Stigmasterol for Bile Salt Binding and Serum Cholesterol Reduction: Synthesis, Interaction Mechanisms, and In Vivo Function

Differences between phytosterols with different structures in regulating cholesterol synthesis, transport and metabolism in Caco-2 cells

Cholesterol stabilization of phospholipid vesicles against bile-induced solubilization

Synthesis of cholesterol analogues and comparison on their effect on plasma cholesterol with β-Sitosterol

Enhancement of Antioxidant Activity in O/W Emulsion and Cholesterol-Reducing Capacity of Epigallocatechin by Derivatization with Representative Phytosterols.

Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media.

Hydrolysis of phytosterol esters in the intestine is required for their cholesterol lowering effects

Additional mechanism for selective absorption of cholesterol and phytosterols

Effect of Surfactant-Bile Interactions on the Solubility of Hydrophobic Drugs in Biorelevant Dissolution Media

Effect of a New b-Sitosterol Analogue on Plasma Lipid Concentrations in Rats 1 )

Crystal substrate inhibition during microbial transformation of phytosterols in Pickering emulsions